About Avida Biomed
Avida Biomed is a company based in Fremont (United States) founded in 2019 was acquired by Agilent in January 2023. Avida Biomed offers products and services including Methyl-Seq Reagents, NGS Library Prep, and Chromatography Supplies. Avida Biomed operates in a competitive market with competitors including Macrogen, Genewiz, BGI, Transnetyx and Acclinate, among others.
- Headquarter Fremont, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Agilent Technologies, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Avida Biomed
Avida Biomed offers a comprehensive portfolio of products and services, including Methyl-Seq Reagents, NGS Library Prep, and Chromatography Supplies.
Reagents for DNA methylation sequencing in genomics workflows
Kits for preparing DNA and RNA libraries for sequencing applications
Tools for separation and analysis in chemical and biological research
Funding Insights of Avida Biomed
Detailed funding history for Avida Biomed
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Avida Biomed
Avida Biomed has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Agilent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified instruments are developed for scientific and laboratory management.
|
Locked | Locked | Locked |
Investor details for Avida Biomed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avida Biomed
Investment portfolio details for Avida Biomed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avida Biomed
Detailed financials for Avida Biomed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avida Biomed Comparisons
Peer comparison for Avida Biomed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avida Biomed
Avida Biomed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Macrogen, Genewiz, BGI, Transnetyx and Acclinate, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Automated genotyping services for murine cell lines are developed.
|
|
| Locked | Locked | Locked |
Clinical trial services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Molecular analysis services for research and drug development are offered.
|
Detailed competitors of Avida Biomed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avida Biomed
Complete news archive for Avida Biomed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avida Biomed
Avida Biomed was founded in 2019.
Avida Biomed is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Avida Biomed was established in 2019 and is based in Fremont, United States. Operations are centered in the biotechnology sector, where molecular diagnostic services are delivered to support precision medicine initiatives. These services encompass testing and analysis for personalized healthcare applications. The companys domain, avidabio.com, facilitates access to its offerings. Focus remains on diagnostic solutions tailored to medical needs in the region.
Avida Biomed offers Methyl-Seq Reagents, NGS Library Prep, and Chromatography Supplies.
Avida Biomed has 1 investor. Key investors include Agilent.